Cited by 94Microbial Metabolites in Food BiotechnologyGalectins and Cancer BiologyGlycosylation and Glycoproteins Research

Glycan recognition at the interface of the intestinal immune system: target for immune modulation via dietary components

de Kivit, Sander, Kraneveld, Aletta D., Garssen, Johan, Willemsen, Linette E.M.·2011·European Journal of Pharmacology

Abstract

The intestinal mucosa is constantly exposed to the luminal content, which includes micro-organisms and dietary components. Prebiotic non-digestible oligosaccharides may be supplemented to the diet to exert modulation of immune responses in the intestine. Short chain galacto- and long chain fructo-oligosaccharides (scGOS/lcFOS), functionally mimicking oligosaccharides present in human milk, have been reported to reduce the development of allergy through modulation of the intestinal microbiota and immune system. Nonetheless, the underlying working mechanisms of scGOS/lcFOS are unclear. Intestinal epithelial cells lining the mucosa are known to express carbohydrate (glycan)-binding receptors that may be involved in modulation of the mucosal immune response. This review aims to provide an overview of glycan-binding receptors, in particular galectins, which are expressed by intestinal epithelial cells and immune cells. In addition, their involvement in health and disease will be addressed, especially in food allergy and inflammatory bowel disease, diseases originating from the gastro-intestinal tract. Insight in the recognition of glycans in the intestinal tract may open new avenues for the treatment of intestinal inflammatory diseases by either nutritional concepts or pharmacological intervention.

Integrity signals

Registry

Crossref · 10.1016/j.ejphar.2011.05.086

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Prebiotic fibers added to the diet might explain its better effects on gastrointestinal function and motor function via beneficial effects on immune function, bowel motility, and microbiota composition that can alter the enteric immune and nervous system and subsequently the central nervous system.

    “Prebiotic fibers added to the diet might explain its better effects on GI-function since GOS and FOS have shown to have beneficial effects on immune function (de Kivit et al., 2011), bowel motility (Meksawan et al., 2014;Scholtens et al., 2014), but they might also contribute to its better efficacy on motor-function since the prebiotic fibers might positively affect microbiota composition that in”

    From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as de Kivit et al., 2011

  • Prebiotic fibers have been shown to have beneficial effects on immune function, bowel motility and constipation that might be relevant for inflammation and gastrointestinal-related symptoms in Parkinson's disease.

    “Prebiotic fibers have been shown to have beneficial effects on immune function (Jeurink et al., 2013)(de Kivit et al., 2011)(van Hoffen et al., 2009), bowel motility and constipation (Meksawan et al., 2014) (Scholtens et al., 2014) (Rasmussen et al., 2014) that might be very relevant for inflammation and GI-related symptoms in PD.”

    From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as de Kivit et al., 2011

The citation lists haven’t been fetched yet

References 106 · Cited by 94

Authors
de Kivit, S., Kraneveld, A. D., Garssen, J., & Willemsen, L. E. M.
Affiliations
  • Utrecht University (NL)
  • Danone (Netherlands) (NL)
Corresponding author
Willemsen, Linette E.M.
Venue
European Journal of Pharmacology
Publisher
Elsevier BV
Published
2011-09
Volume
668
Pages
S124-S132
ISSN
0014-2999 (ISSN-L)
OpenAlex
W2023516396
Cited by
94
References
106
Citations by year
2026: 2 · 2025: 2 · 2024: 6 · 2023: 2 · 2022: 5 · 2021: 11 · 2020: 4 · 2019: 7 · 2018: 2 · 2017: 10 · 2016: 2 · 2015: 5 · 2014: 11 · 2013: 15 · 2012: 10
FWCI
1.37
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Top Institute Pharma
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
  • Life Sciences › Immunology and Microbiology › Immunology › Galectins and Cancer Biology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
Keywords
carbohydrate recognition, galectins, prebiotic oligosaccharides, intestinal mucosa, intestinal epithelial cells, gut microbiota, food allergy, inflammatory bowel disease, immunomodulation, food components
MeSH terms
Animals, Diet, Diet Therapy, Humans, Immune System, Intestines, Polysaccharides, Immunomodulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review